COGT logo

Cogent Biosciences, Inc. (COGT) Depreciation and amortization

annual D&A:

$4.35M+$763.00K(+21.27%)
December 31, 2024

Summary

  • As of today (July 27, 2025), COGT annual depreciation & amortization is $4.35 million, with the most recent change of +$763.00 thousand (+21.27%) on December 31, 2024.
  • During the last 3 years, COGT annual D&A has risen by +$2.36 million (+118.53%).
  • COGT annual D&A is now -25.98% below its all-time high of $5.88 million, reached on December 31, 2022.

Performance

COGT Depreciation and amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCOGTincome statement metrics

quarterly D&A:

$1.14M+$30.00K(+2.71%)
March 31, 2025

Summary

  • As of today (July 27, 2025), COGT quarterly depreciation & amortization is $1.14 million, with the most recent change of +$30.00 thousand (+2.71%) on March 31, 2025.
  • Over the past year, COGT quarterly D&A has increased by +$72.00 thousand (+6.75%).
  • COGT quarterly D&A is now -69.33% below its all-time high of $3.71 million, reached on September 30, 2022.

Performance

COGT quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCOGTincome statement metrics

TTM D&A:

$4.42M+$72.00K(+1.65%)
March 31, 2025

Summary

  • As of today (July 27, 2025), COGT TTM depreciation & amortization is $4.42 million, with the most recent change of +$72.00 thousand (+1.65%) on March 31, 2025.
  • Over the past year, COGT TTM D&A has increased by +$492.00 thousand (+12.52%).
  • COGT TTM D&A is now -32.85% below its all-time high of $6.59 million, reached on June 30, 2023.

Performance

COGT TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCOGTincome statement metrics

COGT Depreciation and amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+21.3%+6.8%+12.5%
3 y3 years+118.5%+103.2%+74.5%
5 y5 years+236.5%+285.8%+264.6%

COGT Depreciation and amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-26.0%+118.5%-69.3%+69.8%-32.9%+93.1%
5 y5-year-26.0%+504.3%-69.3%+6594.1%-32.9%+900.7%
alltimeall time-26.0%+2330.7%-69.3%+6594.1%-32.9%+1491.0%

COGT Depreciation and amortization History

DateAnnualQuarterlyTTM
Mar 2025
-
$1.14M(+2.7%)
$4.42M(+1.7%)
Dec 2024
$4.35M(+21.3%)
$1.11M(+1.0%)
$4.35M(+7.8%)
Sep 2024
-
$1.10M(+1.6%)
$4.04M(+6.4%)
Jun 2024
-
$1.08M(+1.3%)
$3.79M(-3.5%)
Mar 2024
-
$1.07M(+34.3%)
$3.93M(+9.6%)
Dec 2023
$3.59M(-39.0%)
$794.00K(-7.1%)
$3.59M(-3.8%)
Sep 2023
-
$855.00K(-29.7%)
$3.73M(-43.4%)
Jun 2023
-
$1.22M(+68.2%)
$6.59M(+9.0%)
Mar 2023
-
$723.00K(-22.8%)
$6.04M(+2.8%)
Dec 2022
$5.88M(+195.2%)
$937.00K(-74.8%)
$5.88M(+7.1%)
Sep 2022
-
$3.71M(+453.9%)
$5.49M(+139.6%)
Jun 2022
-
$670.00K(+19.6%)
$2.29M(-9.6%)
Mar 2022
-
$560.00K(+2.6%)
$2.53M(+27.3%)
Dec 2021
$1.99M(+176.5%)
$546.00K(+6.2%)
$1.99M(+36.2%)
Sep 2021
-
$514.00K(-43.8%)
$1.46M(+36.6%)
Jun 2021
-
$914.00K(+5276.5%)
$1.07M(+142.1%)
Mar 2021
-
$17.00K(0.0%)
$442.00K(-38.6%)
DateAnnualQuarterlyTTM
Dec 2020
$720.00K(-44.3%)
$17.00K(-86.1%)
$720.00K(-29.2%)
Sep 2020
-
$122.00K(-57.3%)
$1.02M(-16.2%)
Jun 2020
-
$286.00K(-3.1%)
$1.21M(-3.6%)
Mar 2020
-
$295.00K(-6.1%)
$1.26M(-2.7%)
Dec 2019
$1.29M(-2.1%)
$314.00K(-1.3%)
$1.29M(-2.9%)
Sep 2019
-
$318.00K(-3.9%)
$1.33M(-0.9%)
Jun 2019
-
$331.00K(+0.3%)
$1.34M(+0.4%)
Mar 2019
-
$330.00K(-6.3%)
$1.34M(+1.2%)
Dec 2018
$1.32M(+12.8%)
$352.00K(+6.7%)
$1.32M(+3.5%)
Sep 2018
-
$330.00K(+1.5%)
$1.28M(+2.4%)
Jun 2018
-
$325.00K(+3.5%)
$1.25M(+3.2%)
Mar 2018
-
$314.00K(+2.3%)
$1.21M(+3.1%)
Dec 2017
$1.17M(+41.1%)
$307.00K(+2.3%)
$1.17M(+35.5%)
Sep 2017
-
$300.00K(+4.9%)
$864.00K(+53.2%)
Jun 2017
-
$286.00K(+2.9%)
$564.00K(+102.9%)
Mar 2017
-
$278.00K
$278.00K
Dec 2016
$830.00K(+363.7%)
-
-
Dec 2015
$179.00K
-
-

FAQ

  • What is Cogent Biosciences, Inc. annual depreciation & amortization?
  • What is the all time high annual D&A for Cogent Biosciences, Inc.?
  • What is Cogent Biosciences, Inc. annual D&A year-on-year change?
  • What is Cogent Biosciences, Inc. quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Cogent Biosciences, Inc.?
  • What is Cogent Biosciences, Inc. quarterly D&A year-on-year change?
  • What is Cogent Biosciences, Inc. TTM depreciation & amortization?
  • What is the all time high TTM D&A for Cogent Biosciences, Inc.?
  • What is Cogent Biosciences, Inc. TTM D&A year-on-year change?

What is Cogent Biosciences, Inc. annual depreciation & amortization?

The current annual D&A of COGT is $4.35M

What is the all time high annual D&A for Cogent Biosciences, Inc.?

Cogent Biosciences, Inc. all-time high annual depreciation & amortization is $5.88M

What is Cogent Biosciences, Inc. annual D&A year-on-year change?

Over the past year, COGT annual depreciation & amortization has changed by +$763.00K (+21.27%)

What is Cogent Biosciences, Inc. quarterly depreciation & amortization?

The current quarterly D&A of COGT is $1.14M

What is the all time high quarterly D&A for Cogent Biosciences, Inc.?

Cogent Biosciences, Inc. all-time high quarterly depreciation & amortization is $3.71M

What is Cogent Biosciences, Inc. quarterly D&A year-on-year change?

Over the past year, COGT quarterly depreciation & amortization has changed by +$72.00K (+6.75%)

What is Cogent Biosciences, Inc. TTM depreciation & amortization?

The current TTM D&A of COGT is $4.42M

What is the all time high TTM D&A for Cogent Biosciences, Inc.?

Cogent Biosciences, Inc. all-time high TTM depreciation & amortization is $6.59M

What is Cogent Biosciences, Inc. TTM D&A year-on-year change?

Over the past year, COGT TTM depreciation & amortization has changed by +$492.00K (+12.52%)
On this page